Nonradioactive alternative to clinical mixed lymphocyte reaction

Area of Science:

• Immunology
• Cellular immunology
• Transplantation immunology

Background:

• The Mixed Lymphocyte Reaction (MLR) is a crucial functional assay for assessing genetic human leukocyte antigen (HLA) disparity.
• Traditional MLR relies on [3H]thymidine incorporation, posing environmental and administrative challenges due to radioisotope use.
• Development of sensitive, nonradioactive assays for T-cell alloactivation is essential to overcome limitations of radioisotope-based methods.

Purpose of the Study:

• To develop and validate a nonradioactive alternative to the traditional MLR for detecting T-cell alloactivation.
• To establish an assay system utilizing an IL-2-dependent cell line (CTLL20.3) and MTT reduction to quantify IL-2 accumulation.
• To compare the sensitivity and correlation of the novel nonradioactive assay with the established [3H]thymidine-based MLR.

Main Methods:

• Utilized the IL-2-dependent cell line CTLL20.3 for detecting IL-2 accumulation in Mixed Lymphocyte Culture (MLC) supernatants (SNs).
• Employed MTT reduction as an indicator of IL-2 presence, correlating with T-cell alloactivation.
• Optimized assay parameters including CTLL20.3 cell number, SN analysis time, and sensitivity-enhancing manipulations.
• Validated the assay using patient lymphocyte combinations, comparing results with [3H]thymidine incorporation assays.

Main Results:

• Established an optimized nonradioactive assay using CTLL20.3 cells and MTT reduction to detect IL-2 accumulation as a measure of T-cell alloactivation.
• Demonstrated strong correlation between the CTLL20.3-MTT assay and traditional [3H]thymidine assays for identifying MHC incompatibility.
• Observed that the CTLL20.3-MTT assay may offer slightly enhanced sensitivity compared to the conventional clinical MLR.

Conclusions:

• The developed CTLL20.3-MTT assay provides a viable, nonradioactive alternative for functional assessment of HLA disparity.
• This novel method overcomes the environmental and administrative hurdles associated with radioisotope use in MLR.
• The nonradioactive assay shows comparable or potentially superior sensitivity to the traditional MLR, offering a promising tool for clinical and research applications.